Characteristic | RA patients (n = 50) |
---|---|
Demographic | |
Age, years, median (IQR) | 60 (49~ 64) |
Female, n (%) | 38 (76) |
Disease status | |
Disease duration, months, median (IQR) | 38 (14–110) |
ESR (mm/h), median (IQR) | 80 (54~ 105) |
CRP (mg/dl), median (IQR) | 4.37 (1.82~ 6.75) |
Rheumatoid factor-positive, n (%) | 46 (92) |
ACPA-positive, n (%) | 41 (82) |
DAS28, median (IQR) | 5.02 (3.0~ 6.8) |
Previous medications, n (%) | |
Corticosteroids | 19 (38) |
Methotrexate | 20 (40) |
Leflunomide | 6 (12) |
Sulfasalazine | 2 (4) |
Hydroxychloroquine | 7 (14) |
Etanercept | 5 (10) |